Avanos Medical (AVNS) Total Liabilities (2013 - 2026)
Avanos Medical (AVNS) posted Total Liabilities of $268.0 million for Q1 2026, down 9.31% sequentially from $295.5 million in Q4 2025, and little changed YoY from $268.4 million in Q1 2025.
Avanos Medical (AVNS) Total Liabilities (2013 - 2026) Analysis & Trends
Avanos Medical has reported Total Liabilities for 14 years, with the latest figure at $268.0 million in Q1 2026.
- Quarterly Total Liabilities changed 0.15% year-over-year to $268.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $268.0 million (changed 0.15% YoY) and the FY2025 annual result came in at $295.5 million, down 9.27% from the prior year.
- Total Liabilities slipped to $268.0 million in Q1 2026 per AVNS's latest filing, from $295.5 million in the prior quarter.
- Over five years, Total Liabilities peaked at $511.7 million in Q3 2022 and troughed at $262.7 million in Q2 2025.
- A 5-year average of $403.0 million and a median of $433.4 million in 2024 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Liabilities soared 52.29% in 2022, then slumped 39.72% in 2025.
- Over 5 years, Total Liabilities stood at $495.7 million in 2022, then fell by 7.99% to $456.1 million in 2023, then decreased by 28.59% to $325.7 million in 2024, then slipped by 9.27% to $295.5 million in 2025, then dropped by 9.31% to $268.0 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $268.0 million, $295.5 million, and $289.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.94 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 3.14 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.83 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.03 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 17.70 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.51 Bn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 268.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 268.00 Mn |
| Dec 31, 2025 | 295.50 Mn |
| Sep 30, 2025 | 289.70 Mn |
| Jun 30, 2025 | 262.70 Mn |
| Mar 31, 2025 | 268.40 Mn |
| Dec 31, 2024 | 325.70 Mn |
| Sep 30, 2024 | 426.50 Mn |
| Jun 30, 2024 | 435.80 Mn |
| Mar 31, 2024 | 433.40 Mn |
| Dec 31, 2023 | 456.10 Mn |
| Sep 30, 2023 | 502.80 Mn |
| Jun 30, 2023 | 431.90 Mn |
| Mar 31, 2023 | 436.20 Mn |
| Dec 31, 2022 | 495.70 Mn |
| Sep 30, 2022 | 511.70 Mn |
| Jun 30, 2022 | 501.20 Mn |
| Mar 31, 2022 | 510.00 Mn |
| Dec 31, 2021 | 333.00 Mn |
| Sep 30, 2021 | 336.00 Mn |
| Jun 30, 2021 | 387.00 Mn |